Home

Glaxosmithkline (GSK)

Investing

Strong Stocks in a Stormy Market

August has been a nerve-wracking month for investors. But here are five companies with ballast and proven growth.

August 7, 2007

investing

GlaxoSmithKline: The Right Prescription

This British drug maker boasts a balanced, diversified portfolio of medications, a healthy pipeline, ultra-high profitability and a cheap stock.

October 6, 2006